Structural basis for the design of bisubstrate inhibitors of protein kinase CK2 provided by complex structures with the substrate-competitive inhibitor heparin

2021 ◽  
Vol 214 ◽  
pp. 113223
Author(s):  
Alexander Schnitzler ◽  
Karsten Niefind
2020 ◽  
Vol 96 ◽  
pp. 103608 ◽  
Author(s):  
Markus Pietsch ◽  
Kaido Viht ◽  
Alexander Schnitzler ◽  
Ramesh Ekambaram ◽  
Michaela Steinkrüger ◽  
...  

2000 ◽  
Vol 275 (38) ◽  
pp. 29618-29622 ◽  
Author(s):  
Roberto Battistutta ◽  
Stefania Sarno ◽  
Erika De Moliner ◽  
Elena Papinutto ◽  
Giuseppe Zanotti ◽  
...  

FEBS Letters ◽  
2010 ◽  
Vol 585 (1) ◽  
pp. 104-110 ◽  
Author(s):  
Andrew D. Ferguson ◽  
Payal R. Sheth ◽  
Andrea D. Basso ◽  
Sunil Paliwal ◽  
Kimberly Gray ◽  
...  

2017 ◽  
Vol 10 (4) ◽  
pp. 9 ◽  
Author(s):  
Karsten Niefind ◽  
Nils Bischoff ◽  
Andriy Golub ◽  
Volodymyr Bdzhola ◽  
Anatoliy Balanda ◽  
...  

2017 ◽  
Vol 10 (4) ◽  
pp. 98 ◽  
Author(s):  
Jennifer Hochscherf ◽  
Dirk Lindenblatt ◽  
Benedict Witulski ◽  
Robin Birus ◽  
Dagmar Aichele ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Daniel Paprocki ◽  
Maria Winiewska-Szajewska ◽  
Elżbieta Speina ◽  
Róża Kucharczyk ◽  
Jarosław Poznański

Abstract4,5,6,7-Tetrabromo-1H-benzotriazole is widely used as the reference ATP-competitive inhibitor of protein kinase CK2. Herein, we study its new analogs: 5,6-diiodo- and 5,6-diiodo-4,7-dibromo-1H-benzotriazole. We used biophysical (MST, ITC) and biochemical (enzymatic assay) methods to describe the interactions of halogenated benzotriazoles with the catalytic subunit of human protein kinase CK2 (hCK2α). To trace the biological activity, we measured their cytotoxicity against four reference cancer cell lines and the effect on the mitochondrial inner membrane potential. The results obtained lead to the conclusion that iodinated compounds are an attractive alternative to brominated ones. One of them retains the cytotoxicity against selected cancer cell lines of the reference TBBt with a smaller side effect on mitochondrial activity. Both iodinated compounds are candidate leaders in the further development of CK2 inhibitors.


Sign in / Sign up

Export Citation Format

Share Document